Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocarnitine for Reducing ESA Requirements in Hemodialysis
NCT07160452Phase 4Not yet recruiting
- Sponsor
- Shaikh Zayed Hospital
- Start
- Sep 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of levocarnitine in anemia of chronic kidney disease, sponsored by Shaikh Zayed Hospital. Planned start Sep 2025; status: not yet recruiting.
02
Drugs
levocarnitine
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on NCT07160452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07160452.